Low
₹26,615.80
High
₹26,754.75
Low
₹21,846.40
High
₹27,116.20
| Previous Close | ₹26,478.45 |
|---|---|
| Day's Range | ₹26,615.80 - ₹26,754.75 |
| Open | ₹26,683.55 |
| 52 Week Range | ₹21,846.40 - ₹27,116.20 |
| Volume | 34,27,71,219 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Bharat Heavy Electricals Ltd. | 413.50 | |
Capital Goods |
| Steel Authority Of India Ltd. | 174.90 | |
Iron & Steel |
| Vedanta Ltd. | 268.00 | |
Non - Ferrous Metals |
| Hindalco Industries Ltd. | 1029.85 | |
Non - Ferrous Metals |
| The Federal Bank Ltd. | 355.30 | |
Bank |
| Ashok Leyland Ltd. | 173.80 | |
Automobile & Ancillaries |
| Cummins India Ltd. | 5205.00 | |
Automobile & Ancillaries |
| Bharat Forge Ltd. | 2062.00 | |
Automobile & Ancillaries |
| Eicher Motors Ltd. | 8042.00 | |
Automobile & Ancillaries |
| Shriram Finance Ltd. | 1128.20 | |
Finance |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24231.85 | 26373.20 | 22182.55 |
| Nifty IT | 30673.05 | 40301.40 | 25699.10 |
| Nifty Next 50 | 74194.15 | 74878.45 | 59896.10 |
| NIFTY50 USD Index | 8772.75 | 10443.40 | 8132.40 |
| Nifty Bank | 57495.9 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 63671.55 | 64139.05 | 52032.85 |
| Nifty 500 | 23512.95 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18300.65 | 18403.50 | 14804.55 |
| Nifty 100 | 25391.85 | 26975.15 | 22720.45 |
| Nifty FMCG | 47863.25 | 58485.05 | 45334.15 |
Aditya Birla Capital has informed that the NBFC business of the company (‘ABCL’), one of India's leading diversified financial services companies, today announced its entry into the Gold Loan business, marking a strategic expansion of its secured lending portfolio. The Gold Loan offering complements its existing retail and MSME lending franchise, providing customers with a transparent, flexible and collateral-backed credit solution. The Company has planned a phase-wise rollout of 200-300 dedicated Gold Loan branches by March 2027 across high-potential markets. Over the next three years, the ABCL-NBFC business aims to establish a network of around 1,000 Gold Loan branches, building a strong pan-India franchise and further strengthening its presence across the country. A Press Release on the same is enclosed.
The above information is a part of company’s filings submitted to BSE.
Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals (Glenmark) today announced the receipt of U.S. FDA approval1 for Fluticasone Propionate Nasal Spray USP, 0.05 mg/spray. Glenmark’s Fluticasone Propionate Nasal Spray USP is bioequivalent and therapeutically equivalent to the reference listed drug, Flonase®2 Nasal Spray, 0.05 mg/spray of Haleon US Holdings LLC [NDA 020121] and will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA. The company has attached media release.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of NT200ALP30 index is ₹26662.4 as of 2026-08-20.
The total volume of NT200ALP30 index is 342771219.00 as of 2026-08-20.
The percentage change in value of NT200ALP30 index is 0.69% as of 2026-08-20.
The absolute increase in NT200ALP30 index value since the previous trading day is ₹183.95 as of 2026-08-20.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.